Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
Does Regulatory Compliance Matter in False Claims Act Cases?
December 29, 2016
Larry Freedman, a health care and life sciences litigator and Member in the Mintz Washington, DC office, was quoted in this Bloomberg BNA Health Care Blog piece on whether regulatory compliance matters in False Claims Act (FCA) cases.
Consumer safety agency flexes its muscles but is likely to face pushback under Donald Trump
December 27, 2016
Chuck Samuels, a Member in the Mintz DC office, is quoted in an article from The Kansas City Star on the Consumer Product Safety Commission’s (CPSC) efforts in recent years to change its somewhat weaker image to an agency with a penalties system with teeth.
Government Watchdog Taking Close Look at Medicaid Drug Rebates
December 27, 2016
Ellyn Sternfield, a Mintz Health Law attorney and Special Counsel, is quoted in this Bloomberg BNA Health Care Blog on the Health and Human Services Office of Inspector General’s (OIG) announcement on its reviews of Medicaid’s drug rebate program.
Mintz attorneys represented venture capital firm General Catalyst in a $33 million Series B investment in Lemonade, Inc., an insurance startup. General Catalyst led the funding along with GV, Thrive Capital, Tusk Ventures, Aleph, Sequoia, and XL Innovate.
‘Tis the season to give someone a basket of processed meats
December 22, 2016
Dan Herling, a Mintz Member, authored an article in the Daily Journal on the distribution of processed meats during the holiday season.
Trump Enforcement of Foreign Bribery Law Uncertain
December 22, 2016
Mintz Member Linda Bentley was quoted in a Bloomberg BNA Life Sciences Law & Industry Report article on the life sciences industry’s uncertainty regarding the Trump administration’s enforcement of the Foreign Corrupt Practices Act (FCPA).